Investors might want to bet on Korro Bio, Inc. (KRRO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- ...

Here is how Adicet Bio, Inc. (ACET) and Biodesix, Inc. (BDSX) have performed compared to their sector so far this year.

This oncology biotech advancing targeted therapies reported a notable insider sale amid ongoing clinical-stage development.

The biotech sector, once hailed as the next growth engine for the stock market, is experiencing a sharp decline. While the immediate trigger is the "AI frenzy," analysts point to long-standing ...

Passage Bio, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-20, effective July 14, 2025, in order to meet Nasdaq's minimum bid price requirement of $1.00 per share. The ...

On June 25, 2026, investors tracked deal progress as Bio-Techne shares responded to the proposed buyout terms.

Shares of Nuvation Bio (NYSE: NUVB) were skyrocketing 15.7% higher as of 11:20 a.m. ET on Tuesday. The big jump came after two positive developments for the cancer-focused drugmaker. Which news ...

On Thursday, Tevogen Bio Holdings Inc. (NASDAQ:TVGN) announced its top-line revenue forecast for its oncology pipeline, projecting $1 billion in revenue in its launch year and a cumulative 5-year ...

Cabaletta offers a de-risked, breadth-first CAR-T platform for autoimmune diseases, with strong EULAR 2026 data and a ...